This webinar includes high impact areas such as revolutionary biomarker-based trial designs, FDA approval of CAR-T-cell therapies, how to turn 'cold' tumours into 'hot' tumours to improve outcomes of immunotherapy, genetics screens in large populations and discussions of newly approved therapies ie PD-1/PDL-1 targeting in bladder cancer. With an additional focus on the Key Advances in Medicine eBook, published in February 2018.
Is an unique and effective patient-tailored medicine, no matter what cancer type the patient is harbouring, a pipedream or a dawning reality supported by pipeline research and development?
The white paper explains the link between biomarkers, mutations and molecular targets - using NSCLC as an illustrative example of how biomarkers can aid development decisions and support targeted therapy.
SpringerProtocols has the largest number of biomedical and life sciences protocols so researchers can find the right protocol for their lab set-up, without the need to compromise or find workarounds. Browse a selection of protocol eBooks related to Cancer Treatment:
